AbbVie, Inc. (ABBV)
225.35
+2.28
(+1.02%)
USD |
NYSE |
Jun 09, 16:00
225.17
-0.18
(-0.08%)
After-Hours: 20:00
AbbVie Research and Development Expense (Quarterly) : 2.472B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 471.10M |
| Gilead Sciences, Inc. | 1.354B |
| Regeneron Pharmaceuticals, Inc. | 1.420B |
| Travere Therapeutics, Inc. | 57.09M |
| Amgen, Inc. | 1.719B |